Literature DB >> 35664824

Hypereosinophilia: An Unusual Bystander in Cancer.

Cristhiam M Rojas-Hernandez1.   

Abstract

Entities:  

Year:  2020        PMID： 35664824      PMCID： PMC9161664          DOI： 10.36401/JIPO-20-X8

Source DB:  PubMed          Journal:  J Immunother Precis Oncol        ISSN： 2590-017X


× No keyword cloud information.
  9 in total

Review 1.  World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.

Authors:  William Shomali; Jason Gotlib
Journal:  Am J Hematol       Date:  2019-10       Impact factor: 10.047

2.  Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance.

Authors:  M Brigden; C Graydon
Journal:  Arch Pathol Lab Med       Date:  1997-09       Impact factor: 5.534

3.  Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.

Authors:  Florence Roufosse; Aurore de Lavareille; Liliane Schandené; Elie Cogan; Ann Georgelas; Lori Wagner; Liqiang Xi; Mark Raffeld; Michel Goldman; Gerald J Gleich; Amy Klion
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

4.  Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Ionita Ghiran; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-11       Impact factor: 6.215

5.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

6.  Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis.

Authors:  A Kaser; G Brandacher; W Steurer; S Kaser; F A Offner; H Zoller; I Theurl; W Widder; C Molnar; O Ludwiczek; M B Atkins; J W Mier; H Tilg
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

7.  Case Report: Metastatic Dedifferentiated Liposarcoma Presenting as Hypereosinophilia in an Adolescent.

Authors:  Sadhana Balasubramanyam; Joud Hajjar
Journal:  J Immunother Precis Oncol       Date:  2020-10-29

Review 8.  Making eosinophils through subtle shifts in transcription factor expression.

Authors:  Kelly McNagny; Thomas Graf
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

Review 9.  Eosinophils: changing perspectives in health and disease.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Paul S Foster
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.